Shownotes
Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.
This episode covers insights for the business week ended Nov. 6, 2026. This time—Madrigal’s MASH whistleblower; Lilly’s dealmaking to continue; Sanofi hunting late-stage assets; Pfizer raises guidance; and LIB’s PCSK9 pricing.
Story links here.
This and all our other podcasts are available on the Scrip channel on Apple Podcasts and Spotify Podcasts and on TuneIn.
Scrip YouTube Podcasts…

